Hayeshi, R2012-10-192012-10-192012-10Hayeshi, R. Nanomedicine for improved efficacy of tuberculosis drugs – Pharmacokinetic importance. Emerging Researcher Symposium. 4th CSIR Biennial Conference: Real problems relevant solutions, CSIR, Pretoria, 9-10 October 2012http://www.conference2012.csir.co.za/sites/default/files/Rose_Hayeshi_FINAL.pdfhttp://hdl.handle.net/10204/6186Emerging Researcher Symposium. 4th CSIR Biennial Conference: Real problems relevant solutions, CSIR, Pretoria, 9-10 October 2012This presentation focuses on the importance of pharmacokinetics in nanomedicine.enNanomedicineTuberculosisTBPharmacokineticsConference PresentationHayeshi, R. (2012). Nanomedicine for improved efficacy of tuberculosis drugs – Pharmacokinetic importance. http://hdl.handle.net/10204/6186Hayeshi, R. "Nanomedicine for improved efficacy of tuberculosis drugs – Pharmacokinetic importance." (2012): http://hdl.handle.net/10204/6186Hayeshi R, Nanomedicine for improved efficacy of tuberculosis drugs – Pharmacokinetic importance; 2012. http://hdl.handle.net/10204/6186 .TY - Conference Presentation AU - Hayeshi, R AB - This presentation focuses on the importance of pharmacokinetics in nanomedicine. DA - 2012-10 DB - ResearchSpace DP - CSIR KW - Nanomedicine KW - Tuberculosis KW - TB KW - Pharmacokinetics LK - https://researchspace.csir.co.za PY - 2012 T1 - Nanomedicine for improved efficacy of tuberculosis drugs – Pharmacokinetic importance TI - Nanomedicine for improved efficacy of tuberculosis drugs – Pharmacokinetic importance UR - http://hdl.handle.net/10204/6186 ER -